Showing results (1571-1580 of 11,725) with videos related to

Sort By:
Pageof 1,173
European Heart Journal|February 11, 2025
Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II SurveyMagdy Abdelhamid, Amir M Abdel Meged, Bernard Prendergast, et al.
European Heart Journal|August 6, 2024
Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk scoreBorja Rivero-Santana, Jesús Saldaña-García, Juan Caro-Codón, et al.
European Heart Journal|August 8, 2024
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndromeSahej Bains, Lucilla Giammarino, Saranda Nimani, et al.
European Heart Journal|August 30, 2024
Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II surveyJulia Mascherbauer, Andreas Kammerlander, Christian Nitsche, et al.
European Heart Journal|August 30, 2024
Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesisMaría A Zuriaga, Zhi Yu, Nuria Matesanz, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
European Heart Journal|August 30, 2024
Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCOREJulien Dreyfus, Fernando Juarez-Casso, Alessandra Sala, et al.
European Heart Journal|September 1, 2024
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trialCaroline J Coats, Ahmad Masri, Roberto Barriales-Villa, et al.
European Heart Journal|August 31, 2024
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trialAtsushi Tanaka, Keisuke Kida, Yuya Matsue, et al.
European Heart Journal|August 31, 2024
Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patientsAnna S Ondracek, Taras Afonyushkin, Adrienne Aszlan, et al.
Pageof 1,173